Market Analysis on Gynecology & Women Healthcare
Women 60 years of age or older account for half of all ovarian cancer cases. For instance, according to Globocan, it is predicted that by 2040, there would be 434,184 new cases of ovarian cancer worldwide. The market for gynecology medications will experience growth over the predicted period due to the rising incidence of ovarian cancer. The therapeutics area of the gynecological pharmaceuticals market will have the greatest growth in non-hormonal therapy, with worldwide sales expected to reach $7.08 billion by 2026. Gynecology Congress 2023 is to bring together the top experts and delegates for an in-depth discussion on Gynaecology and Women's Health which will be held from April 03-04, 2023 in Barcelona, Spain. Gynecology Conference will serve as an international venue for the transmission of research findings, innovative ideas, and practical development experiences. The market for gynecological pharmaceuticals is anticipated to increase from $24.68 billion in 2021 to $26.36 billion in 2022 at a compound annual growth rate (CAGR) of 6.8% as COVID's impacts on the world economy start to fade.